Downloads Categories - Any -AnnualsCurrent Proxy MaterialsForm 8937GovernanceOld CalendarProxy Year None2014201320122011201020092008200720062005200420032002 Feb 09, 2010 Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.4 KB Feb 09, 2010 CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.7 KB Jan 29, 2010 Enzon Completes Sale of Specialty Pharmaceutical Business 12.3 KB Jan 27, 2010 Enzon Stockholders Approve Sale of Specialty Pharmaceutical Business 9.7 KB Jan 06, 2010 Enzon Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer 11.2 KB Dec 22, 2009 Enzon Sets Date of Special Meeting of Stockholders to Approve Sale of Specialty Pharmaceutical Business 11.6 KB Dec 03, 2009 Enzon Board Authorizes Share Repurchase of up to $50 Million 10.5 KB Nov 19, 2009 Enzon Presents Data at 2009 EORTC Meeting 18.2 KB Nov 16, 2009 Enzon to Present Data at EORTC-NCI-AACR 13.8 KB Nov 09, 2009 Enzon Announces Agreement to Sell Specialty Pharmaceutical Business 21 KB Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page next › Last page last »
Feb 09, 2010 Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.4 KB
Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.4 KB
Feb 09, 2010 CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.7 KB
CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow 9.7 KB
Dec 22, 2009 Enzon Sets Date of Special Meeting of Stockholders to Approve Sale of Specialty Pharmaceutical Business 11.6 KB
Enzon Sets Date of Special Meeting of Stockholders to Approve Sale of Specialty Pharmaceutical Business 11.6 KB